Acute central nervous system toxicity during treatment of pediatric acute lymphoblastic leukemia: phenotypes, risk factors and genotypes

Stavroula Anastasopoulou^*, Rikke Linnemann Nielsen, Bodil Als-Nielsen, Joanna Banerjee, Mats A. Eriksson, Marianne Helenius, Mats M. Heyman, Inga Maria Johannsdottir, Olafur Gisli Jonsson, Stuart MacGregor, Marion K. Mateos, Chelsea Mayoh, Sirje Mikkel, Ida Hed Myrberg, Riitta Niinimäki, Kjeld Schmiegelow, Mervi Taskinen, Goda Vaitkeviciene, Anna Warnqvist, Benjamin WolthersArja Harila-Saari, Susanna Ranta

^*Corresponding author for this work

Bioinformatics
Department of Health Technology

Karolinska University Hospital
Rigshospitalet
University of Helsinki
Karolinska Institutet
Oslo University Hospital
Landspitali University Hospital
QIMR Berghofer Medical Research Institute
University of New South Wales
University of Tartu
University of Oulu
Vilnius University
Uppsala University

Research output: Contribution to journal › Journal article › Research › peer-review

Acute central nervous system toxicity during treatment of pediatric acute lymphoblastic leukemia: phenotypes, risk factors and genotypes

Fingerprint

Medicine and Dentistry

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology